WeLeader Biomedical Co., Ltd. (TPEX: 7713)

Market Cap	2.96B
Revenue	n/a
Net Income	n/a
Shares Out	41.58M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Jun 13, 2024

Volume	3,000
Open	71.30
Previous Close	71.30
Day's Range	71.30 - 71.30
52-Week Range	64.70 - 85.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About WeLeader Biomedical

WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system. The company also provides blood gas electrolyte analyzers, urine analyzers, integrated fully automatic biochemical analyzers, fully automatic electronic luminescence immunoassay products, fully automatic modular biochemical immune assay products, TTA automated pre-processing products, POCT centr...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 1992
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7713